Cat. No. |
Product Name |
Information |
PC-25155 |
TXH1033
FtsZ inhibitor
|
TXH1033 is the orally active, carboxamide prodrug of TXH9179, which is a next-generation benzamide-based FtsZ inhibitor, TXH1033 is rapidly hydrolyzed to TXH9179 by serum acetylcholinesterases, exhibited in vivo efficacyin mouse model of systemic (peritonitis) MRSA infection. |
PC-25154 |
TXH9179
FtsZ inhibitor
|
TXH9179 is a next-generation benzamide-based FtsZ inhibitor, exhibits braod antibacterial activity against Clinical Isolates of MSSA, MRSA, VISA, VRSA, and LRSA with MIC of 0.25-0.5 ug/mL. |
PC-25152 |
UCM53
FtsZ inhibitor
|
UCM53 is a specfic small molecule inhibitor of bacterial cell division targeting the GTP-binding site of FtsZ with Kb of 1.3 uM, inhibits the growth of the Gram-positive bacterium B. subtilis with MIC of 13 uM. |
PC-25151 |
UCM05
FtsZ inhibitor
|
UCM05 is a specfic small molecule inhibitor of bacterial cell division targeting the GTP-binding site of FtsZ with Kb of 43 uM, inhibits the growth of the Gram-positive bacterium B. subtilis with MIC of 100 uM, also is a fatty acid synthase (FASN) inhibitor wiht activity against HER2+ breast cancer. |
PC-25079 |
Bacterial SPase inhibitor MD3
LepB inhibitor
|
Bacterial SPase inhibitor MD3 a small molecule inhibitor of bacterial type I signal peptidases (SPases) with IC50 of 10 uM against P. aeruginosa LepB protein. |
PC-25078 |
Pezulepistat
LepB inhibitor
|
Pezulepistat (Compound II) is a potent, selective inhibitor of bacterial type 1 signal peptidase LepB, shows serum MIC value of 0.5 μM against E. coli 25922, exhibits broad spectrum antibiotic activity. |
PC-25077 |
Mtb LepB inhibitor 17af
LepB inhibitor
|
Mtb LepB inhibitor 17af is a potent, small molecule inhibitor of M. tuberculosis type I signal peptidase (LepB) with IC90 of 0.41 uM for LepB under-expressing (LepB-UE) strain of M. tuberculosis, shows IC50 of 1.2 uM against wild-type Mtb. |
PC-24913 |
Mtb GpsI inhibitor X1
GpsI inhibitor
|
Mtb GpsI inhibitor X1 is a specific small molecule inhibitor of mycobacterial PNPase, guanosine penta-phosphate synthase I (GpsI), with IC50 of 1.95 uM. |
PC-24906 |
JNJ-6640
Mtb PurF inhibitor
|
JNJ-6640 is a first-in-class potent, selective inhibitor targeting Mycobacterium tuberculosis (Mtb) PurF (IC50=1 nM), exhibits high potency against M. |
PC-24883 |
HC2210
Mtb inhibitor
|
HC2210 is a novel orally bioavailable small molecule Mycobacterium tuberculosis (Mtb) growth inhibitor with EC50 of 50 nM. |
PC-24836 |
Isoniazid
Antibiotic
|
Isoniazid (INH) is an antibiotic with bactericidal activity, has anti-tuberculostatic activity. |
PC-24835 |
Levofloxacin
Antibiotic
|
Levofloxacin ((-)-Ofloxacin) is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria, inhibits DNA gyrase and Topoisomerase IV. |